9 results
S-3ASR
EX-1.2
APGE
Apogee Therapeutics, Inc.
12 Aug 24
Automatic shelf registration
5:25pm
consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed appropriate.
(c) Research Analyst Independence. The Company
DEF 14A
APGE
Apogee Therapeutics, Inc.
24 Apr 24
Definitive proxy
4:15pm
to assure that these services do not impair the auditor’s independence. These procedures generally approve the performance of specific services subject … communications with the Audit Committee concerning independence, and the Audit Committee has discussed with EY its independence. Based on the foregoing
10-K
2023 FY
APGE
Apogee Therapeutics, Inc.
5 Mar 24
Annual report
6:15am
, and Director Independence
14. Principal Accountant Fees and Services
PART IV
15. Exhibits
16. Form 10-K Summary
Explanatory Note
As used in this Annual … Transactions, and Director Independence.
Certain Relationships and Transactions
The following is a summary of each transaction or series of similar
DRS
APGE
Apogee Therapeutics, Inc.
9 Feb 24
Draft registration statement
12:00am
— Anti-Takeover Effects of Our Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws and Delaware Law.”
Director Independence …
Our Board has reviewed the independence of all directors in light of each director’s (or any family member’s, if applicable) affiliations
424B4
APGE
Apogee Therapeutics, Inc.
17 Jul 23
Prospectus supplement with pricing info
4:08pm
Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws and Delaware Law.”
Director Independence
In connection with this offering … and our listing on The Nasdaq Global Market, our Board has reviewed the independence of all directors in light of each director’s (or any family
S-1
6eh6uwl1jaiu
22 Jun 23
IPO registration
4:19pm
DRS/A
v65sf2fi
5 Jun 23
Draft registration statement (amended)
12:00am
DRS
fkecgc
28 Apr 23
Draft registration statement
12:00am
- Prev
- 1
- Next